Assessment tools for soft signs

Psychiatric Annals

Volumn 33, Issue 3, 2003, Pages 170-176

  Bombin, Igor ^a   Arango, Celso ^b,c   Buchanan, Robert W ^c,d  

^a Ctro Estatal Atencion Daao Cerebral   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d Univ of Maryland School of Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN REGION; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE MARKER; HUMAN; MEDICAL ASSESSMENT; MENTAL PATIENT; METHODOLOGY; MOTOR ACTIVITY; MOTOR COORDINATION; MOTOR SYSTEM; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; PHENOTYPE; PREVALENCE; QUANTITATIVE ANALYSIS; RATING SCALE; REFLEX; RELIABILITY; REVIEW; SCHIZOPHRENIA; SENSORY SYSTEM; STANDARD; SYNDROME;

EID: 2042479364     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-20030301-06     Document Type: Review

References (34)

1. Heinrichs DW, Buchanan RW. Significance and meaning of neurological signs in schizophrenia. Am J Psychiatry. 1988;145:11-8.
2. Arango C, Bartko JJ, Gold JM, Buchanan RW. Prediction of neuropsychological performance by neurological signs in schizophrenia. Am J Psychiatry, 1999;156:1349-1357.
3. Walker EF, Savoie T, Davis D. Neuromotor precursors of schizophrenia. Schizophr Bull. 1994;20:441-451.
4. Rubin P, Vorstrup S, Hemmingsen R, et al. Neurological abnormalities in patients with schizophrenia or schizophreniform disorder at first admission to hospital: correlations with computerized tomography and regional cerebral blood flow findings. Acta Psychiatr Scand. 1994;90:385-390.
5. Marcus J, Hans SL, Lewow E, Wilkinson L, Burack CM. Neurological findings in high-risk children: childhood assessment and 5-year follow-up. Schizophr Bull. 1985;11:85-100.
6. Ismail BT, Cantor-Graae E, Cardenal S, McNeil TF. Neurological abnormalities in schizophrenia: clinical, etiological, and demographic correlates. Schizophr Res. 1998;30:229-238.
7. Egan MF, Hyde TM, Bonomo JB, et al. Relative risk of neurological signs in siblings of patients with schizophrenia. Am J Psychiatry. 2001;158:1827-1234.
8. Woods BT, Kinney DK, Yurgelun-Todd D. Neurologic abnormalities in schizophrenic patients and their families. I. Comparison of schizophrenic, bipolar, and substance abuse patients and normal controls. Arch Gen Psychiatry. 1986;43:657-663.
9. Madsen AL, Vorstrup S, Rubin P, Larsen JK, Hemmingsen R. Neurological abnormalities in schizophrenic patients: a prospective follow-up study 5 years after first admission. Acta Psychiatr Scand. 1999;100:119-125.
10. Smith RC, Hussain MI, Chowdhury SA, Stearns A. Stability of neurological soft signs in chronically hospitalized schizophrenic patients. J Neuropsychiatry Clin Neurosci. 1999;11:91-96.
11. Kinney DK, Yurgelun-Todd DA, Woods BT. Hard neurologic signs and psychopathology in relatives of schizophrenic patients. Psychiatry Res. 1991;39:45-53.
12. Rossi A, De Cataldo S, Di Michele V, et al. Neurological soft signs in schizophrenia. Br J Psychiatry. 1990;157:735-739.
13. Quitkin F, Rifkin A, Klein DF. Neurologic soft signs in schizophrenia and character disorders. Organicity in schizophrenia with premorbid asociality and emotionally unstable character disorders. Arch Gen Psychiatry. 1976;33:845-853.
14. Cox SM, Ludwig AM. Neurological soft signs and psychopathology, I: findings in schizophrenia. J Nerv Ment Dis. 1979;167:161-165.
15. Lane A, Colgan K, Moynihan F, et al. Schizophrenia and neurological soft signs: gender differences in clinical correlates and antecedent factors. Psychiatry Res. 1996;64:105-114.
16. Schröder J, Niethammer R, Geider FJ, et al. Neurological soft signs in schizophrenia. Schizophr Res. 1992;6:25-30.
17. Schröder J, Buchsbaum MS, Siegel BV, Geider FJ, Niethammer R. Structural and functional correlates of subsyndromes in chronic schizophrenia. Psychopathology. 1995;28:38-45.
18. Convit A, Jaeger J, Lin SP, Meisner M, Volavka J. Prediction of assaultiveness in psychiatric inpatients: is it possible?. In: Brizer DA, Crowner ML, eds. Current Approaches in the Prediction of Violence. Washington, DC: American Psychiatric Press; 1989:37-62.
19. Convit A, Volavka J, Czobor P, de Asis J, Evangelista C. Effect of subtle neurological dysfunction on response to haloperidol treatment in schizophrenia. Am J Psychiatry. 1994;151:49-56.
20. Krakowski MI, Czobor P. Clinical symptoms, neurological impairment, and prediction of violence in psychiatric inpatients. Hospital & Community Psychiatry. 1994;45:700-705.
21. Wong AH, Voruganti LN, Heslegrave RJ, Awad AG. Neurocognitive deficits and neurological signs in schizophrenia. Schizophr Res 1997;23:139-146.
22. Chen EY, Shapleske J, Luque R, et al. The Cambridge Neurological Inventory: a clinical instrument for assessment of soft neurological signs in psychiatric patients. Psychiatry Res. 1995;56:183-204.
23. Chen EY, Lam LC, Chen RY, Nguyen DG. Negative symptoms, neurological signs, and neuropsychological impairments in 204 Hong Kong Chinese patients with schizophrenia. Br J Psychiatry. 1996;168:227-233.
24. Chen YL, Chen YH, Mak FL. Soft neurological signs in schizophrenic patients and their nonpsychotic siblings. J Nerv Ment Dis. 2000;188:84-89.
25. Chen EY, Kwok CL, Au JW, Chen RY, Lau BS. Progressive deterioration of soft neurological signs in chronic schizophrenic patients. Acta Psychiatr Scand. 2000;102:342-349.
26. Chen EY, Lam LC, Chen RY, Nguyen DG, Kwok CL, Au JW. Neurological signs and sustained attention impairment in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2001; 251:1-5.
27. Buchanan RW, Heinrichs DW. The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res. 1989;27:335-350.
28. Mohr F, Hubmann W, Cohen R, et al. Neurological soft signs in schizophrenia: assessment and correlates. Eur Arch Psychiatry Clin Neurosci. 1996;246:240-248.
29. Sanders RD, Keshavan MS, Schooler NR. Neurological examination abnormalities in neuroleptic-naive patients with first-break schizophrenia: preliminary results. Am J Psychiatry. 1994;151:1231-1233.
30. Smith RC, Kadewari RP. Neurological soft signs and response to risperidone in chronic schizophrenia. Biol Psychiatry. 1996;40: 1056-1059.
31. Sanders RD, Forman SD, Pierri JN, et al. Inter-rater reliability of the neurological examination in schizophrenia. Schizophr Res. 1998;29:287-292.
32. Malla AK, Norman RM, Aguilar O, Cortese L. Relationship between neurological 'soft signs' and syndromes of schizophrenia. Acta Psychiatr Scand. 1997;96:274-280.
33. Buchanan RW, Kirkpatrick B, Heinrichs DW, Carpenter WT Jr. Clinical correlates of the deficit syndrome of schizophrenia. Am J Psychiatry. 1990;147:290-294.
34. Arango C, Kirkpatrick B, Buchanan RW. Neurological signs and the heterogeneity of schizophrenia. Am J Psychiatry. 2000;157:560-565.